Sign in

CIK 0001131399

  • Large accelerated filer
Ticker
GLAXF
Exchange
NYSE, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
Other
Phone
+44 2080475000
Business address
79 NEW OXFORD STREET, LONDON, United Kingdom, WC1A 1DG
Former names
GLAXOSMITHKLINE PLC

Securities

  • GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) NYSE
  • GLAXF Common stock OTC
  1. 4 Insider Changes in Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Open-market buy 10% owner bought 130,473 shares at $4,913,613.18 ($641,093,852,434)
  5. 4 Open-market buy 10% owner bought 3,064,407 shares at $111,850,855.50 ($342,756,544,550,189)
  6. 4 Insider Changes in Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy 10% owner bought 193,563 shares at $6,699,215.43 ($1,296,720,236,277)
  9. 4 Open-market buy 10% owner bought 116,527 shares at $2,567,089.81 ($299,135,274,290)
  10. 4 Open-market buy 10% owner bought 280,348 shares at $6,265,777.80 ($1,756,598,274,674)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy 10% owner bought 316,334 shares at $28.21 ($8,923,782)
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Open-market buy 10% owner bought 10,000,000 shares at $21.29 ($212,887,000)
  18. 4 Insider Changes in Ownership
  19. 4 Open-market buy 10% owner bought 88,468 shares at $18.12 ($1,603,040)
  20. 3 Insider Initial Statement of Ownership

Page 5 of 7 · 132 filings